February
19
2020
Olanzapine 5 mg plus standard antiemetic therapy for the
prevention of chemotherapy-induced nausea and vomiting
(J-FORCE): a multicentre, randomised..
February
19
2020
Entrectinib in ROS1 fusion-positive non-small-cell lung
cancer: integrated analysis of three phase 1–2 trials
February
19
2020
Entrectinib in patients with advanced or metastatic NTRK
fusion-positive solid tumours: integrated analysis of
three phase 1–2 trials
February
19
2020
CAR T-cell product performance in haematological
malignancies before and after marketing authorisation
February
19
2020
Artificial intelligence for diagnosis and grading of prostate
cancer in biopsies: a population-based, diagnostic study
February
19
2020
Automated deep-learning system for Gleason grading of
prostate cancer using biopsies: a diagnostic study
February
19
2020
Belantamab mafodotin for relapsed or refractory multiple
myeloma (DREAMM-2): a two-arm, randomised, open-label,
phase 2 study
February
19
2020
International standards for the analysis of quality-of-life and
patient-reported outcome endpoints in cancer randomised
controlled trials: recommend..
February
19
2020
Transcriptomic signatures related to the obesity paradox in
patients with clear cell renal cell carcinoma: a cohort study
February
19
2020
Orbital metastases from malignant mesothelioma